EZZ Life Science Holdings Ltd
EZZ Life Science Holdings Limited engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and South-East Asia. The company operates through two segments, Brought in Lines and Company Owned Products. It is involved in the wholesale distribution of the EAORON branded skin care products to retailers; and direct-to-consum… Read more
EZZ Life Science Holdings Ltd (EZZ) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: -0.198x
Based on the latest financial reports, EZZ Life Science Holdings Ltd (EZZ) has a cash flow conversion efficiency ratio of -0.198x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-5.50 Million) by net assets (AU$27.81 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
EZZ Life Science Holdings Ltd - Cash Flow Conversion Efficiency Trend (2018–2024)
This chart illustrates how EZZ Life Science Holdings Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
EZZ Life Science Holdings Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of EZZ Life Science Holdings Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Refinaria de Petróleos de Manguinhos S.A
SA:RPMG3
|
-0.004x |
|
Chemlite Innovation Berhad
KLSE:0348
|
N/A |
|
Cavitation Techs Inc
OTCQB:CVAT
|
1.159x |
|
Ntaw Holdings Ltd
AU:NTD
|
0.021x |
|
Aprogen Healthcare & Games Inc
KQ:109960
|
0.002x |
|
NAXS Nordic Access Buyout Fund AB
ST:NAXS
|
-0.003x |
|
Sundaram Brake Linings Limited
NSE:SUNDRMBRAK
|
0.250x |
|
Bank Cimb Niaga Tbk
JK:BNGA
|
-0.027x |
Annual Cash Flow Conversion Efficiency for EZZ Life Science Holdings Ltd (2018–2024)
The table below shows the annual cash flow conversion efficiency of EZZ Life Science Holdings Ltd from 2018 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | AU$28.09 Million | AU$4.35 Million | 0.155x | -46.20% |
| 2023-12-31 | AU$21.32 Million | AU$6.14 Million | 0.288x | +4.67% |
| 2022-12-31 | AU$14.58 Million | AU$4.01 Million | 0.275x | +64.84% |
| 2021-12-31 | AU$11.39 Million | AU$1.90 Million | 0.167x | +565.80% |
| 2020-12-31 | AU$10.11 Million | AU$253.53K | 0.025x | -93.38% |
| 2019-12-31 | AU$7.85 Million | AU$2.97 Million | 0.379x | -25.04% |
| 2018-12-31 | AU$823.91K | AU$416.33K | 0.505x | -- |